K-ras transformed fibroblasts have been shown to have a stronger dependence from glycolysis, reduced oxidative phosphorylation ability and a fragility towards glucose depletion compared to their immortalized, normal counterparts. In this paper, using RNA profiling assays and metabolic perturbations, we report changes in expression of genes encoding mitochondrial proteins and alterations in mitochondrial morphology that correlate with mitochondrial functionality. In fact, unlike normal cells, transformed cells show reduced ATP content and inability to modify mitochondria morphology upon glucose depletion. Being reverted by GEF-DN expression, such morphological and functional changes are directly connected to Ras activation. Taken together with reported partial mitochondrial uncoupling and more sustained apoptosis of transformed cells, our results indicate that activation of the Ras pathway strikingly impacts on energy and signaling-related aspects of mitochondria functionality, that in turn may affect the terminal phenotype of transformed cells.
1. Introduction
Mitochondria and cancer
Mitochondria are dynamic eukaryotic organelles that have long been known to play a central role in cellular metabolism, notably in ATP production by oxidative phosphorylation [1, 2] . The primary metabolic function of mitochondria is oxidative phosphorylation (OXPHOS), an energy-generating process that couples oxidation of respiratory substrates to the synthesis of ATP. Mitochondria are delimited by two membranes dividing them into two different compartments: the matrix and the inter membrane space. The OXPHOS system comprises four redox complexes (numbered I to IV, making up the respiratory chain), and complex V (i.e. the ATP synthase), all located in the mitochondrial inner membrane. The respiratory chain transfers electrons from NADH and FADH 2 , generated through the breakdown of substrates in the matrix, or imported from the cytosol through specific transport systems, to molecular oxygen, the terminal electron acceptor. Energy released by oxidation of these substrates is used to generate an electro-chemical proton gradient (ΔΨ) across the mitochondrial inner membrane. ATP synthase couples utilization of this gradient to the synthesis of ATP. Each complex of the respiratory chain and complex V consist of multiple polypeptide subunits, some encoded by nuclear genes and some encoded by mitochondrial DNA. Protein composition, stoichiometric ratio of the various protein subunits, post-translational modifications, tissue specificity and the role of each and every subunit in the function of mitochondrial complexes are still under investigation. In mammals the complexes I to V are composed respectively by 42, 4, 11, 13 and 15 subunits. Respiratory chain complexes comprise core subunits that are necessary for complex activity and other subunits, possibly playing ancillary or modulatory roles, while all subunits of ATP-synthase seem required for activity [1, 2] .
Besides ATP synthesis, mitochondria are involved in several other key metabolic processes such as oxidative decarboxylation of pyruvate, tricarboxylic acid cycle, and fatty acid oxidation. Mitochondria are the site of important biosynthetic reactions, such as amino acids and heme biosynthesis and part of gluconeogenesis. Mitochondria take part in intracellular homeostasis of inorganic ions such as calcium and phosphate, as well as in the balance of NAD + /NADH, since part of NAD + , produced by NADH oxidation in the respiratory chain, goes back to the cytosol where it is required for glycolysis. Several enzymes of the urea cycle are also localized in mitochondrial matrix. Besides their central role in metabolic activity, mitochondria have been shown more recently to have a central role in the cascade of events that leads to programmed cell death. In fact, evidence has been gathered indicating a pro-apoptotic role for several molecules usually associated to mitochondria (cytochrome C, AIF, EndoG, Bax) as well as a role in damping the apoptotic cascade of proteolytic enzymes (caspase) by other molecules usually associated to mitochondria [3, 4] . Thus, these findings assign to mitochondria a more critical role in the responses of cells to a multiplicity of physiological and genetic stresses, inter-organelle communication, cell proliferation and cell death [5] [6] [7] [8] [9] [10] .
The study of energy metabolism of transformed cells has been a central issue of cancer research until the interest shifted to genetic approaches. As early as 1930, Otto Warburg proposed that cancer cells may have impaired mitochondrial function and that this alteration would result in the elevated rate of glycolysis that is a common feature of most tumors [11] . During the 1970s H.A. Krebs stated that the elevated rate of glycolysis " may be a symptom of cancer, but not a primary cause" [12] [13] [14] , a concept recently restated by Robert Weinberg who wrote that "aerobic glycolysis is an epiphenomenon of cell transformation rather than a casually important process" [15] . Although the glycolytic phenotype of many cancer cells and tumors has been demonstrated at both the biochemical and molecular levels [16] [17] [18] [19] [20] [21] [22] [23] [24] , the presumed impairment of cancer mitochondrial function has never been unambiguously established. In fact, to this day, we still do not know the role, if any, that mitochondria play in neoplastic transformation and/or in maintaining or promoting the transformed state. Recent studies highlighted that mitochondrial dysfunction is one of the most recurrent features of cancer cells [25] [26] [27] [28] , given that substantial differences between the mitochondria of normal and cancer cells have been reported at microscopic, molecular, biochemical, metabolic and genetic level.
A fundamental role for hypoxia in emergence of mitochondria dysfunction is supported from experimental and clinical evidence. Indeed, hypoxia has been shown to alter the expression of genes involved in stress response, anaerobic metabolism, angiogenesis, tissue remodeling, and cell to cell contact acting in an epigenetic and non-epigenetic fashions [29] . All these phenomena participate in the process of "adaptive response" of cancer cells to hypoxic conditions contributing to their growth advantage. The importance of hypoxia in tumor development is substantiated by several reports indicating that in developing tumors the oxygen level declines more than glucose level [30] [31] [32] [33] . Cancer cells would counteract oxygen shortage by hyperactivation of glycolysis to produce ATP. The secondary effect of stimulated glycolysis is the accumulation of lactate in the environment with a direct consequence on the extracellular pH that becomes more acidic [30] [31] [32] [33] . Cells that are able to survive in acidic environment will be strongly advantaged, and some authors have shown, in several cancer cells, an upregulation of the Na + -H + exchange and vacuolar H + -ATPase that facilitates survival in an acidic environment [34] [35] [36] . Moreover, an acidic environment induces apoptosis in normal neighbor cells and degradation of extracellular matrix that in turn facilitates migration and invasion of the surrounding tissues by well-adapted cancer cells. In this regard, it is widely recognized that a significant number of tumors reveals over-expression of HIF1α, which participates in the induction of some glycolytic enzymes [8, 33, [37] [38] [39] [40] [41] [42] [43] [44] , of angiogenetic processes by inducing the VEGF expression [45, 46] and in the migration processes by inducing different proteases, such as urokinase Plasminogen Activators [47, 48] . On the other hand, other authors support the view that the metabolic shift to glycolysis directly results from oncogenic mutations of elements of the signal transduction pathways that control glucose uptake by the cells or of transcription factors that control the expression of glycolytic and mitochondrial genes [10, 18, 22, [49] [50] [51] [52] . For these reasons, the molecular mechanisms that promote the expression of an aberrant energy metabolism in tumor and cancer cells are presently a subject of renewed debate.
Alterations of mitochondria in cancer
Mitochondrial alterations specifically associated with their bioenergetics function have been observed in cancer cells. Mutations in mitochondrial DNA (mtDNA) are commonly found in a variety of cancers [38, 53, 54] . Microscopic study of tumors revealed mitochondrial hyperplasia, and up-regulated expression of mitochondrial cytochrome oxidase II mRNA in malignant breast tissues has been observed [55] . Expression analysis in glioblastoma tissues showed reduction of cytochrome C oxidase subunit II and III (COX II, COX III), ATP synthase subunit 6 (ATP 6), NADH dehydrogenase subunit 1 and 4 (ND1 and ND4) transcripts [56] .
Only recently, mitochondrial enzymes have been directly implicated in hereditary neoplasia. Germline heterozygous mutations in nuclear genes encoding subunits of mitochondrial complex II (succinate-ubiquinone oxydoreductase, composed of four subunits -SDHA, SDHB, SDHC and SDHD -and involved in electron transport and in tricarboxylic-acid cycle) cause inherited tumoral syndromes [46, 48, [57] [58] [59] , while homozygous mutations in the SDHA-encoding gene cause neurodegenerative disorders [60, 61] . Mutations in the gene encoding fumarate hydratase (FH, fumarase that converts fumarate to malate) cause inherited neoplastic syndromes, as well as to kidney cancers [61, [63] [64] [65] , associated with a reduction in dosage of SDH or FH-encoding genes. Complete or near complete loss of enzyme function occurs only in the somatic tumor cells. Reduced mitochondrial SDH or FH activity might affect apoptosis and angiogenesis induction, both hallmarks of tumorigenesis [46, 48, 58, 59] . In fact, defects in energy production may block energy-dependent apoptotic processes, and upregulate angiogenesis, due to increased HIF1α stability resulting from succinate inhibition of HIF1α prolyl-hydroxylase [61, 62] . Further evidence of the importance of mtDNA mutations in neoplastic transformation comes from studies of complex IV (COX IV) mutations in prostate cancer [66] . Mitochondrial cytochrome c oxidase activity in total cellular homogenate and in mitochondrial samples from cultured human carcinoma cell lines has been shown to be significantly lower than that measured in the control epithelial cell line [25] .
Specific repression of the expression of the β-catalytic subunit of the H + -ATP synthase (β-F1-ATPase), a rate-limiting component of mitochondrial oxidative phosphorylation, has been documented in rat hepatocarcinomas, in several human tumors [67] , and notably of carcinomas [68, 69] . Decreased expression of β-F1-ATPase observed in the inner core of some carcinomas is accompanied by concurrent up-regulation of glycolytic enzymes in most of the human solid tumors analyzed and might result from a partial hypoxic environment in such tumors. Reduced adenine nucleotide translocase activity has been reported in certain hepatoma versus normal liver mitochondria [70, 71] and it has been correlated to the aggressiveness of cancer cells [72] . Evidence has been collected indicating that pathogenic mtDNA mutations that impinge on mitochondrial energy transduction do play a relevant role in the etiology of cancer by any of the following mechanisms: excessive reactive oxygen species production, reduced cellular apoptotic potential or altered mitochondria to nucleus signaling in a cellular invasive phenotype [54, 73] , suggesting that altered glycolysis of cancer cells could be a consequence of mitochondrial dysfunction.
A fibroblast model for the study of mouse mitochondrial function in transformed cells
As briefly summarized above, mitochondria are involved in different, interacting intracellular networks in both normal and transformed cells. If one wants to identify the network(s) that presides and regulates the process under investigation [74] , it is necessary to start by analyzing the network(s) under study using a defined, genetically tractable model both for normal and transformed cells in which the transformed phenotype can be switched on and off by defined molecular events.
We have developed an experimental system comprising normal, K-ras transformed and reverted, isogenic cell lines using NIH3T3 fibroblasts. The use of NIH3T3 cells to assay the transforming ability of potential and known oncogenes is well documented. Developed by Tordaro and Green [75] as a cell line for transformation studies, this mouse fibroblastic cell line is largely employed for its indefinite growth in culture, retention of contact inhibition, and ease of transformation due to mutations or expression of introduced genes. The ability of transformed 3T3 to overcome contact inhibition when plated in soft agar is a powerful tool, used to examine the oncogenic potentialities of genes such as Ras [76] , sphingosine kinase [77] and the Gprotein linked T151M mutant calcium sensing receptor (CaR) [78] . Moreover several reports found coherent correlation between the results obtained in this cellular model with findings in tumor tissues and animal models [79] [80] [81] [82] .
Ras proteins are intracellular switches whose activation state (i.e. their binding to GDP and GTP) controls downstream pathways leading to cell growth and differentiation. The activation state of Ras proteins is governed through the competing action of GTPase Activating Proteins (GAP) and Guanine nucleotide Exchange Factors (GEF). Mutation of the ras gene is a critical event in the onset of different malignant phenotypes. Also deregulation of either GAP or GEF activity may result in hypo-or hyper-activation of downstream pathway (s), so that for instance over-expression of a GEF or inactivation a GAP may both result in cell transformation [83] [84] [85] .
Research performed in our laboratory indicates that a single amino acid change within the catalytic domain of the mammalian GEF CDC25
Mm turns this molecule into a dominant negative protein (called GEF-DN). GEF-DN is able to efficiently displace wild-type GEF from p21 ras and to originate a stable Ras-GEF binary complex due to the reduced affinity of the nucleotide-free Ras-GEF complex for the incoming nucleotide [86] . This "Ras-sequestering property" can be utilized to attenuate Ras signal transduction pathways in mouse fibroblasts transformed by oncogenic ras, since GEF-DN expression downregulates Ras activity both in vitro and in vivo and induces a reversion of the transformed phenotype on the basis of morphology, anchorage independent growth and reduction of Ras-dependent tumor formation in nude mice [87] . Thus, the use of three cell lines: normal NIH3T3 mouse fibroblasts (that we refer to as normal, or N); NIH3T3 cells transformed by an activated form of the K-ras oncogene [88, 89] (that we refer to as transformed, or T) and K-ras transformed NIH3T3 fibroblasts that stably over-express the GEF-DN (that we refer to as reverted or R [87] ) allows us to directly assess the role played by the Ras activation in the any given studied phenotype.
In this paper, using an RNA profiling assay and metabolic perturbations, we report changes in expression of genes encoding mitochondrial proteins and alteration in mitochondrial morphology that correlate with mitochondrial functionality. In fact transformed cells show a reduction of ATP cellular content in correlation to glucose depletion and inability to modify the mitochondria morphology as normal cell does. Such morphological and functional changes are directly connected to Ras activation, since they are reverted by GEF-DN expression. Together with the reported partial uncoupling and larger fraction of apoptotic cells in the transformed line, our results indicate that activation of the Ras pathway strikingly impacts on energetic and signaling-related aspects of mitochondria functionality that in turn may affect the terminal phenotype of the transformed cell.
Materials and methods

Cell culture
Normal mouse fibroblasts (obtained from the ATCC, Manassas, VA, USA) and a K-Ras-transformed normal-derived cell line, 226.4.1 [90] , were routinely grown in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) containing 10% newborn calf serum, 4 mM glutamax, 100 U/ml penicillin and 100 mg/ml streptomycin (normal growth medium), at 37°C in a humidified atmosphere of 5% CO2. The reverted cell line, stably and constitutively expressing the dominant mutant Cdc25W1056E (GEF-DN) [87] was maintained in normal growth medium supplemented with 0.7 mg/ml geneticin (G418; Sigma-Aldrich Inc., St. Louis, MO, USA). Cells were passaged using trypsinethylenediaminetetraacetic acid (EDTA) (Invitrogen) and maintained in culture for 48 h before experimental manipulation. To verify the cell response to the glucose depletion, the cells were grown in medium with 4 mM glutamax and without glucose and sodium pyruvate (Invitrogen) supplemented with the appropriate concentration of glucose (25 and 1 mM).
RNA preparation and Affymetrix Analysis
For the Affymetrix Gene Chip screening the three cell lines were plated 3000 cells/cm 2 in high glucose (25 mM). After 2 days the cells were detached to prepare the mRNAs and the relative cRNAs. Total RNA was prepared using Trizol reagent (GIBCO-BRL, Grand Island, NY, USA), following the manufacturer's protocol. Double-strand cDNA was synthesized from total RNA using Superscript™ cDNA Synthesis kit (Life Technologies, Carlsbad, CA, USA) and the oligo T-7-(dT)24 primer that contained a T-7 RNA polymerase site. cDNA was in vitro transcribed using the T7 BioArray High Yield RNA Transcript Labeling Kit (Enzo Biochem, Farming Dale, NY, USA) to produce biotinylated cRNA. Labeled cRNA was isolated using an RNeasy Mini Kit column (Qiagen Inc., Valencia, CA, USA). Purified cRNA was fragmented to 200-300 mer cRNA using a fragmentation buffer as suggested by Affymetrix protocol. Housekeeping controls α-actin and GAPDH genes served as endogenous markers and were added to the sample to monitor the quality of the target.
Biotin-labeled cRNAs were hybridized to an MG_U74Av2 Affymetrix Gene Chip. Hybridization experiments were repeated twice using independent cRNA probes synthesized with RNA from two independent sets of cells. Data presented in this work represent the average of both experiments.
Raw data were analyzed using Affymetrix Gene Chip software Mass 5.1. Fold change was calculated using the Affymetrix Gene Chip software with a Comparison Analysis where two samples, hybridized to two Gene Chip probe arrays of the same type, are compared with different types of algorithm against each other in order to detect and quantify changes in gene expression. Results were further elaborated through replica and statistical methods using various software.
Semiquantitative reverse-transcription-PCR
RNA was extracted from cells cultured as described above. Total RNA was incubated with DNase I RNase-Free (Abgene, New York, USA) at 37°C for 1 h.
The RNA was quantified measuring the absorbance at 260 and 280 nm in a spectrometer Lambda EZ 201 (PerkinElmer) and then stored at − 80°C.
Five micrograms of total RNA were reverse-transcribed with oligo dT by using the Superscript™ III RT-PCR First-Strand Synthesis System for RT-PCR (Invitrogen Corp., Carlsbad, CA, USA).
One microliter of the RT product was amplified with primer pairs specific for the genes studied. Specifically for UCP-3: forward ATGAGTTTTGCC-TCCATTCG reverse AAGGAGGGCACAAATCCTTT; TFAM: forward TAGGAAAATTGCAGCCCTGT reverse CTTCAGCCATCTGCTCTTCC; TOMM40: forward TCCAGGTGACCCACACAGTA reverse CCAGCTGA-TACCCAAAGGAG; TST: forward CCCACTTTGGGGACTATGTG reverse TTCTCGAAGCCATCTTTCGT; COX6c: forward CACAGATGCGTG-GTCTTCTG reverse CATAGTTCAGGAGCGCAGGT; COXI: forward GCA-ACCCTACACGGAGGTAA reverse AGGTTGGTTCCTCGAATGTG; COXII: forward TCTCCCCTCTCTACGCATTC reverse TCAGAGCATTGGCCATA-GAA; COXIII: forward AGGCCACCACACTCCTATTG reverse TGGAATC-CAGTAGCCATGAA. As internal control of PCR assays were designed specific primers for vinculine transcript VCL: forward GGGTTTGCAAAGGAATT-TTGG reverse CAGGAAGCAGCTCTTTGACA. The reaction mixture of 30 μl contained 1/30 volume of cDNA, 200 nM of each dNTP, 1 unit of REDAccuTaq DNA Polymerase (Sigma-Aldrich S.r.l. Milan, Italy), 10× buffer (supplied with enzyme), and 0.5 μM each of the forward and reverse primers. The mixture was subjected to amplification using an Eppendorf Mastercycler (Eppendorf, Hamburg, Germany). The reaction with each couple of primers was performed with an initial denaturation at 95°C for 2 min, followed by 20-30 cycles of denaturation at 95°C for 30 s (different cycles were used to avoid a saturating amplification), annealing at 56°C for 1 min, and extension at 72°C for 1 min. A final 5 min extension step was added after the last cycle. Fifteen μl of RT-PCR product were loaded on 1.5% agarose gel and visualized by ethidium bromide staining and photographed under UV light.
Digital imaging microscopy for mitochondrial morphology in living cells
For the visualization of mitochondrial morphology in living cells we used normal, transformed and reverted cells cultured in high and low glucose (1 mM) and attached on cover glasses treated with 0.2% gelatin. To visualize the mitochondria MitoTracker Green FM (200 nM) and CMXRos (MitoTracker Red) (60 nM) (Molecular Probes Inc., Eugene, OR, USA) were used, adding the dyes directly in the culture medium for 39′ at 37°C. Then the cover glasses were washed twice with PBS and directly analyzed under a Nikon ECLIPSE 90i fluorescence microscope equipped with a b/w CCD camera (HamamatsuCoolSnap, Hamamatsu Corporation, Japan), using Plan Apo objective (60× oil; numerical aperture 1.4) and Plan Fluor objective (100×; numerical aperture 1.3). Analysis of the images was also performed using Z-stacks images acquired on a motorized Nikon ECLIPSE 90i (Nikon Corporation, Tokyo, Japan). The images were deconvolved using the iterative algorithm in MetaMorph 7 and evaluated as best focus intensity projections.
Mitochondrial mass and potential analysis in living cells
Mitochondrial mass and potential were determined with the probes MitoTracker Green (60 nM) and CMXRos (MitoTracker Red) (60 nM) (Molecular Probes) using fluorescence-activated cell sorter (FACScan, BectonDickinson). Briefly, cells were trypsinized by treatment with 0.25% trypsin, then were suspended in 1 ml of PBS + 10% FCS (0.5 × 10 6 cells per analysis) containing the two dyes separately at the above indicated final concentrations and labeled for 30 min at 37°C in the dark. Subsequently cells were washed once in PBS + 10% FCS and promptly used for flow cytometric analysis. In some experiments, the cells were pretreated for 10 min with 50 μM carbonyl cyanide 3-chlorophenylhydrazone (CCCP, Sigma-Aldrich S.r.l. Milan, Italy) and stains added to the CCCP containing solution for an additional 30 min at 37°C. The unbound dyes were then removed with one wash, as above, and promptly used for flow cytometric analysis. The percentage and the mean value of mass and potential were calculated for each sample and corrected for autofluorescence obtained from samples of unlabeled cells. Data analysis was performed with WinMDI software.
ATP and ADP quantification
Intracellular ATP and ADP contents were determined based luciferin/ luciferase method with use of ApoSensor ATP-ADP ratio bioluminescent assay kit (Eppendorf, Hamburg, Germany), following the manufacturer's instructions. Briefly, the cells supplemented with high or low glucose, were washed with PBS, detached from plates by using trypsin/EDTA solution and then counted. For each assay 10,000 cells/sample were used, and each experiment was performed in duplicate. The RLU values recorded by Lumat LB9507 luminometer (Berthold Technologies, Bad Wildbad, Germany) were normalized by protein concentration determined for each sample by the method of Bradford using Bio-Rad protein assay (Bio-Rad Laboratories, Milan, Italy).
Results
Transcriptional profiling of genes encoding mitochondrial proteins in normal, transformed and reverted mouse fibroblasts
Transcriptional profiling of normal, transformed and reverted mouse fibroblasts has been reported [10] . Here we extend such an analysis to expression of genes encoding mitochondrial proteins, taking in consideration for this purpose also genes whose regulation was scored as one fold change in two independent experiments. Microarray analysis was validated by RT-PCR on 5-regulated transcripts, using vinculin as a non-changing control. RNA profiling and RT-PCR results for the selected RNAs showed strong correlation (Fig. 1C) .
As shown in Fig. 1A , around 6% of total genes scored as regulated in transformed cells vs. normal cells (with a fold change ≥ 1 or ≤−1) are mitochondrial genes. Moreover, if we extend this estimation adding the results of the transcriptional analysis reported in our previous paper [10] , we observe that around 10% of total regulated genes (with a fold change ≥ 1 or ≤−1) in the comparison between transformed cells vs. normal cells, are linked to energy-production pathways, indicating that oncogenic k-ras induces a strong remodeling of metabolism during the transformation process. Detailed analysis of these genes encoding mitochondrial proteins (Fig.  1B) showed that several genes encoding subunits of cytochrome oxidase were either up-or down-regulated in transformed vs. normal cells. RNA levels of the mitochondrial encoded COX proteins (I, II and III), that are not present onto the Affymetrix chip, were tested by RT-PCR. The level of these RNAs was not affected in k-ras-transformed cells (Fig.  1C) , suggesting that assembly of the COX complex may be impaired in the transformed cell line. Interestingly, transformed cells showed up-regulation of the cytochrome c oxidase assembly protein COX 17, a key mitochondrial copper chaperone involved in the assembly of cytochrome c oxidase, which has been found to be over-expressed in nonsmall cell lung cancer [91] . Expression of several genes encoding subunits of ATP synthase (F 1 F 0 , an oligomer of about 14 polypeptides that are all essential for its catalytic activity) was also altered in transformed cells.
Cellular control over adaptive changes in mitochondrial content requires ability to sense the requirement for additional mitochondrial energy production, followed by triggering of signaling pathways that culminate in an increased and coordinated expression of "respiratory" genes and ensuing upregulation of mitochondrial function. These processes are controlled by different transcription factors and it was interesting to find some important regulators of mitochondrial biogenesis, integrity and functionality differentially expressed in transformed cells. As shown in Fig. 1B , mitochondrial transcription factor A (TFAM), essential for the maintenance of mtDNA [92] , was up-regulated in transformed cells. In the same cells, another well-characterized example of regulation of metabolic pathways, the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) [93] , appeared to be down-regulated. PGC-1α activates gene expression through specific interaction with transcription factors that bind the promoters of genes encoding metabolic enzymes. Two tissue-specific factors as the muscle enhancer factor (MEF2A) and hepatocyte nuclear factor (HNF4) were found down-regulated. Other transcription factors, such as the nuclear factors erythroid-related and -derived Nrf1 and Nfe2l3, involved in the activation of transcription of a series of genes induced in defensive response to antioxidants were also found to be down-regulated.
Developing mitochondria acquire most of their proteins by the uptake of mitochondrial preproteins from the cytosol [1] . To mediate this protein import, both mitochondrial membranes contain independent protein transport systems: the Tom machinery in the outer membrane and the Tim machinery in the inner membrane. Both TOM40 and syntaxin 2, necessary proteins for the transport process were found to be up-regulated in transformed cells [94] [95] [96] . Tim44, which serves as an adaptor protein for the binding of mtHsp70 to the membrane, that participates to the processing of preprotein after cleavage of the presequence [97, 98] , also was found to be down-regulated in transformed cells. Another protein that has been found downregulated in transformed cells was Uncoupling protein 3 (UCP3). UCP3 belongs to a protein family that comprises UCP1, 2 and 3. These proteins are involved in several mitochondrial processes and in different human pathologies [65, 99, 100] . We found other mitochondrial genes, indicated as various processes in Fig. 1B , both up-and down-regulated in transformed cells.
These k-ras-induced effects are substantially reverted by GEF-DN expression (Fig. 1B compare column T/R with R/T), since they take place under normoxic conditions, they are not an adaptive response of transformed cells to oxygen limitation.
Alterations in mitochondria morphology of transformed cells is reverted by expression of the GEF-DN
The penetrance of the transformed phenotype in mouse 3T3 fibroblasts stably transfected with the k-ras oncogene is dependent on glucose availability [10] . Thus, normal, transformed and reverted fibroblasts were grown in media supplemented with either normal (25 mM) or low (1 mM) initial glucose concentration. Cells were followed for at least 96 h, i.e. from the moment of seeding to when they either reached confluence or started to grow in multi strata or to die. Experiments reported in this and the following paragraphs refer to the abovementioned experimental set-up.
In a first set of experiments we analyzed mitochondria morphology by fluorescence microscopy of cells stained with MitoTracker Green FM, a dye that becomes fluorescent once it accumulates in the lipid environment of mitochondria. As shown in Fig. 2(1) , panels A, C, D, F and magnifications, mitochondria of normal and reverted cells, after 24 h of growth in medium supplemented with 25 mM initial glucose concentration, appeared fragmented, with short and long rods partially clustered in the perinuclear region. The same analysis performed on transformed cells showed a more fragmented mitochondrial configuration, less organized structures and no clustering in the perinuclear region (Fig. 2(1) , panels B, E and magnification). The differences in mitochondrial structures were analyzed also at 96 h after plating in the same initial glucose concentration, time at which normal and reverted cells showed an increased G1 fraction due to contact inhibition, while transformed cells continued to grow [10] . Compared to the earlier time point, normal and reverted cells showed a more interconnected mitochondrial network and a decreased perinuclear clustering ( Fig. 2(2) panels A, C, D, F and magnifications), while transformed cells ( Fig. 2(2) panels B, E and magnification) showed mitochondrial fragmentation and appearance of a larger number of cytoplasmatic, diffuse small mitochondrial spheres, structures that could be related to the beginning of apoptotic process, observed at low but consistent frequency at this time point only in transformed cells (ref. [10] and data not shown).
Mitochondria of normal cells grown for 24 h in medium supplemented with 1 mM initial glucose concentration were more fragmented and less clustered in the perinuclear region than the same cells after 24 h of growth in medium supplemented with 25 mM initial glucose concentration (compare panel A, D and magnification in Figs. 3((1) and 2 (1)). Reverted cells were highly similar to normal cells with more evident cytoplasmic redistribution and decreased perinuclear localization (Fig. 3(1) , panel C, F and magnification). On the contrary, no significant redistribution of mitochondria was observed in transformed cells, whose staining pattern was very similar to that of cells grown in 25 mM glucose (compare panel B, E and magnification in Figs. 3((1) and 2(1) ). After 96 h of growth in medium supplemented with 1 mM initial glucose concentration, the mitochondrial reticulum of normal cells appeared more extended in long thinner processes different from the pattern observed in cells grown in 25 mM glucose at the same time point (compare Panels A, D and magnification in Figs. 3(3(2) and 2(2) ). A similar morphology was observed in reverted cells, except that the mitochondrial elongations appeared thicker than in normal cells (Fig. 3(2) , panels C, F and magnification). Transformed cells showed mitochondrial fragmentation similar to the one observed in high glucose condition (Fig. 3(2) , panels B, E and magnification). In low glucose conditions, transformed cells showed a notable increase of apoptosis, while normal and reverted cells strongly accumulate in G1 phase of cell cycle ( [10] and data not shown).
Alteration in mitochondrial mass and potential of transformed cells is reverted by expression of the GEF-DN
Cells grown as described in the previous section were analyzed for the distribution of mitochondrial mass and potential by flow cytometry. Cells were independently stained with MitoTracker Green FM, (see previous chapter) whose fluorescence monitors total mitochondrial mass and MitoTracker Red, a dye whose fluorescence is dependent on mitochondrial potential (ΔΨ). Specificity of MitoTracker Red has been first verified by flow cytometry. Fig. 4A , B and C shows the fluorescence level obtained by flow cytometry -with or without treatment with 50 μM CCCP, a mitochondrial depolarizer -in normal, transformed and reverted cells (panels A, B, C, respectively). After detachment from the plates, each cell line was treated for 10 min with 50 μM CCCP and then labeled with the MitoTracker Red for additionally 30 min, to analyze the mitochondrial potential. As shown in the Fig. 4A , B and C the three cell lines showed a strong reduction of potential after the treatment with CCCP (compare in the three panels the red curves with blue curves) indicating the specificity of the dye for mitochondrial potential. Specificity of MitoTracker Red, as well as of MitoTracker Green was further evaluated by microscopy. As shown in Fig. 4 when the cells treated with (Fig. 4D, E and F) or without (Fig. 4G , H and I) CCCP were loaded with both MitoTracker Red (MTR) and MitoTracker Green FM (MTG) and then imaged, they showed only a reduction in red staining (MTR) but not of green staining (MTG). In fact the outcome of merging the pictures obtained by the two dyes gave as results a yellow staining in absence of the uncoupler agent CCCP (Fig. 4G, H and I ) and only a green staining in presence of the same agent (Fig. 4D, E and F) , indicating a reduction of mitochondrial potential and a minor effect, if any, on mitochondrial mass (MTG staining), as we already observed using CCCP and MTG staining by flow cytometry (data not shown).
Data for mitochondrial mass are reported in Fig. 5 and data for mitochondrial potential in Growth in media supplemented with 1 mM initial glucose concentration gave a similar pattern for MF, but while the maximum MF reached by normal and reverted cells was lower than in 25 mM glucose, the maximal MF reached by transformed cells was the same as for the cells grown in 25 mM, so that in this condition transformed cells displayed the highest mitochondrial mass. Interestingly at this time point, two distinct subpopulations were readily apparent also in transformed cells.
Parallel samples were analyzed for mitochondrial ΔΨ by staining with MitoTracker Red (Fig. 6 ). Staining pattern was quite similar to that observed for MitoTracker Green FM staining, i.e. the fraction of unstained cells (LL) decreased with time in both normal and reverted cells, while it remained high in transformed cells. MF steadily increased with time in all cell lines. As observed with MitoTracker Green staining, the MF value was higher for normal and reverted cells grown in 25 mM glucose concentration, while transformed cells displayed the higher MF value after growth in media supplemented with 1 mM initial glucose concentration. Little, if any, evidence for two sub-populations within stained cells was apparent.
Effect of glucose availability on cellular ATP therein normal, transformed and reverted cell lines
Glucose is the main substrate for intracellular ATP generation. We have previously shown that the transformed cell line has a high rate of glycolysis, necessary to sustain its enhanced proliferative capacity, accompanied by a larger production of lactate and a partial uncoupling of mitochondrial respiration chain [10] . The result of the analysis of mitochondrial potential (ΔΨ), mitochondria propriety strongly associated with the capacity to generate ATP, performed on the cells grown in high and low glucose availability, showed an increasing potential along the time-course and little differences between the three cell lines. Therefore we decided to evaluate the intracellular ATP content in cells grown in high and low glucose availability. When the measurement of ATP levels was performed in active proliferating cells (24 h in 25 and 1 mM glucose) the three cell lines showed similar ATP levels ( Fig. 7A and B) and a low ADP/ATP ratio ( Fig. 7C and D) . After 96 h of growth in high glucose medium (25 mM) the amount of ATP contained in the three cell lines decreased by 35%, 32% and 28% respectively for normal, transformed and reverted cells when compared to values obtained at 24 h (Fig. 7A and B) , resulting in a slight increase of the ADP/ATP ratio ( Fig. 7C and D) . In normal cells, the drop in ATP level after 96 h of growth in low glucose medium was the same observed in high glucose media (36%). Strikingly, ATP level dropped significantly (77%) in transformed cells at the same time point, while an intermediate drop (55%) was observed in reverted cells (Fig. 7B) . As a result, the ADP/ATP ratio in transformed cells increased dramatically as compared to normal and reverted cell lines (Fig. 7D ).
Discussion
Increasing evidence accumulated in recent years, confirms previous observations indicating that energy metabolism of cancer cells and tumors significantly differs from that of normal cells and healthy tissues. Tumor cells have been showed to have a higher glycolytic rate attributed to mitochondrial dysfunction and/or hypoxic environment of developing tumor, a condition that would force cancer cells to use essentially glycolysis to generate ATP. Mitochondrial dysfunctions have been shown to be due in part to mtDNA mutation and/or aberrant expression of metabolic and mitochondrial enzymes, while hypoxia is due to low vascularization that limits oxygen supply in growing tumors.
Ras activation and mitochondrial dysfunction
While the relation between oncogenes and tumor suppressors with onset of tumor phenotype has been well dissected in terms of deregulation of some fundamental cellular processes as cell cycle, survival, apoptosis and migration, less is known about the influence of oncogenes on energy metabolism of tumors. A correlation between Myc activation and p53 inactivation and altered expression of genes encoding glycolytic and mitochondrial proteins has been reported [20, 22, [101] [102] [103] [104] [105] [106] [107] . Correlations between oncogenic Ras and energy metabolism have also been reported [51] . A fully transformed state, obtained by combined expression of different transforming proteins (telomerase, large and small T antigen and H-Ras) showed a correlation between tumor aggressiveness, dependence on glycolytic energy production and decreased dependence on mitochondrial energy production [23] . Inhibition of Ras using the Ras inhibitor trans-farnesylthiosalicylic acid (FTS) or Ras antisense showed down-regulation of HIF-1α, glycolysis and ATP with a consequent increased apoptosis [108] or up-regulation of mitochondrial enzymes [109] . The relation between Ras pathways and biogenesis and activity of mitochondria has been more thoroughly investigated in yeast, where it has been shown that Ras proteins transmit information on nutritional state to mitochondria by regulating expression and activity of mitochondrial proteins [39, [110] [111] [112] .
Here we make use of a model of immortalized mouse fibroblasts and isogenic k-ras transformed and GEF-DN reverted cells (see Introduction and refs. [10] and [87] ), to directly correlate oncogenic ras activation with mitochondrial (dys) function. Results obtained here and elsewhere [10] by a combination of techniques are summarized in Fig. 8 . Color-coding refers to transcriptional regulation in transformed vs. normal cells as follows: red, up-regulation; green, down-regulation; yellow, no change. Cyan-colored proteins indicate that no RNA was detected by RNA profiling assays. In transformed cells the expression of oncogenic K-Ras protein induces a higher rate of glycolysis (red arrow), resulting in accumulation of lactic acid in culture medium, a reduction of fatty acid biosynthesis (green arrow) and a partial uncoupling of mitochondria. These phenomena are substantiated by a transcriptional remodeling of several genes that regulate different pathways (i.e. glycolysis, mitochondrial respiration and cell cycle) most likely necessary to adapt the metabolism of transformed cells to proliferate and survive in normoxic and hypoxic environment, conditions observed in early and late steps of developing tumors. Transcriptional profiling of normal and transformed cells showed that several genes encoding mitochondrial proteins are either up-regulated (subunits colored in red) or down-regulated (subunits colored in green) in transformed cells as compared to normal or reverted cells. Genes whose expression did not change in transformed cells are shown in yellow, while genes not identified in the Affymetrix screen are shown in cyan. This transcriptional remodeling influences the morphology and the capacity to adapt the mitochondria to variation in substrate availability (bottom part of picture). In fact while normal cells increase mitochondrial mass and mitochondrial interconnections (Bottom B and C), probably to facilitate optimal use of the available substrate, transformed cells that essentially rely on glycolysis, are able to proliferate until glucose is available (Bottom B) because in low glucose (Bottom C), despite their increase in mitochondrial potential, they go in apoptosis probably due to uncoupled mitochondria (Bottom A) and fragmented mitochondria, characteristics often observed in apoptotic cells or in non-functional mitochondria. GEF-DN expression reverts the transformed phenotype to one very close to the normal cells. Direct interaction with Ras is shown by heavy black line while "global" phenotypic effects are indicate by thin line (see the bottom part of the figure).
An increased glycolytic flux, down-regulated expression of several genes involved in fatty acid biosynthesis, unbalanced transcription of genes encoding subunits of the pyruvate dehydrogenase complex, subunits of respiratory complex II and IV as well as of ATP synthase was observed in rastransformed fibroblasts vs. their normal and reverted counterparts (Figs. 1 and 8 and ref. [10] ). Altered transcription of genes encoding subunits of complexes IV and ATP synthase has been associated with regulation of mitochondrial activity [113] and tumor progression [66] [67] [68] [69] 114] . Moreover, changes in subunit composition of cytochrome c oxidase, observed in different tissues or after hypoxic treatment, is associated to changes in the activity of the complex itself [59, 115] . Our results suggest an unbalanced composition of the COX complex, with subunits encoded by nuclear genes being affected more then those encoded by mitochondrial DNA (Fig. 1 ), in keeping with observation made in prostate, ovarian, colon, esophageal and breast cancer, where an altered ratio between some nuclearencoded subunits (IV, Vb and VIc) to mitochondrial-encoded subunits (I, II and III) has been proposed to alter the rate of oxidative metabolism [66, 116] . Evidence linking expression of ATP-synthase subunits with the rate of oxidative metabolism, has been reported in several tumor models [56, [117] [118] [119] [120] .
RNA profiling assays also indicated down-regulation of some key transcriptional regulators involved in the expression of nuclear and mitochondrial respiratory genes and other proteins involved in mitochondria functionality (see Fig. 8 ). Interestingly, the down-regulation of the transcriptional coactivator PGC-1α appears, that plays an essential role in mitochondrial biogenesis, induction of genes of respiratory chain, fatty acid oxidation, heme biosynthetic pathways, and that can be stimulated by environmental signaling followed by variation of cAMP levels in the cells [121] [122] [123] . Also interesting, the down-regulation of UCP3 protein appears. In fact, while the great number of studies carried out on this protein did not completely clarify its function, several reports indicate that it is involved in the enhancement of proton conductance when is activated by ROS metabolism, and that this might be an important way to attenuate mitochondrial ROS production and the consequent oxidative damage [65, 99, 100] . Other authors showed a correlation between levels of expression of UCP3 with fatty acid transport and oxidation in muscle [124] [125] [126] , or glucose metabolism in neuronal cells and UCP3 disrupted mice [125] [126] [127] [128] [129] .
By taking into account that a large number of reports underline the importance of efficient oxidative phosphorylation, and in particular the strong involvement of complexes IV and V, in the execution of apoptosis [44, 105, [130] [131] [132] , our data converge to indicate a remodeling of energy metabolism and partial uncoupling of mitochondria [10] , as summarized in the bottom panels in Fig. 8 . Transformed cells do not increase oxygen consumption in presence of uncoupler DNP, while normal and reverted cells do. Transformed cells respond to glucose shortage by substantially increasing ROS production and apoptotic activity, while normal and reverted cells arrest in G1. These responses are coherent with several findings reported in the literature. For instance, deregulation of mitochondrial activity induced by oncogenic K-ras should influence energetic metabolism, as shown by inability to respond to DNP (ref. [10] , Fig. 8 bottom A) and to produce ATP in low glucose (Fig. 7D) , through increased ROS production [10] lead to apoptosis, in ras transformed cells [91, [133] [134] [135] . Such event is more evident in cells grown in low initial glucose concentration (ref. [10] , Fig. 8  bottom B and C) .
Taken together, the transcriptional data presented in this report indicate that deregulation of mitochondrial related genes may contribute to the metabolic shift associated with K-Ras transforming activity, also in consideration that reverted cells, in which the GEF-DN is able to strongly decrease the level of Ras-GTP [86, 87] , showed opposite regulation when compared to the transformed cells, thereby supporting the notion that reported responses are all linked to K-ras over-expression.
Dynamic alterations of mitochondrial mass and morphology in transformed cells
Mitochondria are dynamic organelles that can change in number and morphology during development, cell cycle, as function of substrate availability and during the apoptotic processes. In fact, at least under some conditions, mitochondria in mammalian cells form a physically interconnected network that may represent an efficient system for energy delivery, calcium exchange, intermitochondrial DNA (mtDNA) complementation through exchange of genomes between mitochondria (reviewed in [136] ). This complex network is regulated by processes of fusion and fission whose rate can be modulated by growth conditions, ultimately bringing to an alteration in mitochondrial number and size. Variations of mitochondrial morphology have been shown to correlate with the switch from oxidative phosphorylation to glycolysis and vice versa. A decrease in mitochondrial connectivity leading to formation of short, round mitochondria has also been associated with conditions that compromise mitochondrial function [137, 138] .
Here we show that growing normal and transformed cells exhibit different mitochondrial morphology. Microscopic analysis of mitochondria in growing normal cells (24 h, 25 mM glucose) showed a less fragmented and organized structure positioned around nucleus that became interconnected and filamentous in cells arresting in G1 phase (96 h, 25 mM glucose). These morphological changes are influenced by glucose availability and cell cycle distribution (that is changing during the time course of the experiment, ref. [10] and data not shown). Mitochondria remodeling is tightly controlled by multiple proteins involved in fusion and fission, while organelle distribution is regulated through attachments to microtubules and actin filaments [139] [140] [141] [142] . Cell cycle-dependent changes in mitochondria morphology have been previously reported [42] and proposed to be strongly correlated to energy production in relation to the cell cycle and to the metabolic status of the cells. Fragmentation of mitochondrial mass and its localization in the perinuclear region of the cells [42, 143] has been associated with the requirement of a metabolism focused on energy production, protein and lipid synthesis for the next mitotic division. In transformed cells mitochondria appeared as a less defined structure at 24 h and fragmented at 96 h that could reflect the higher percentage of S phase cells at 96 h when compared to normal cells. Fragmentation observed in transformed cells may indicate also a less active mitochondria, often observed in apoptotic cells or due to the switch to production of ATP by glycolysis (ref. [10] and Fig. 8 bottom B and C) . The parallel analysis of mitochondrial mass and potential offers support to the hypothesis that mitochondria of transformed cells are less active. In fact normal and reverted cells, in presence of fermentable substrate (25 mM glucose) together with a major connection of mitochondrial network, showed an increase of both mitochondrial mass and potential, while transformed cells showed lower mitochondrial mass and potential in relation to fragmented mitochondria. This difference is even more striking by taking into account that a large fraction of transformed cells remained unstained. Time-course-dependent strongly suggest that ATP production in transformed cells is largely glucosedependent, since after 96 h of growth, all three cell lines have used all glucose, but only transformed cells are unable to sustain ATP production. Further, analysis of ATP content in cells grown in 25 mM glucose and 50 μM CCCP for 24 h, showed reduction of total ATP only in normal and revertant cell lines, confirming that transformed cells rely on glycolysis more that on oxidative phosphorylation (data not shown).
Final remarks
The results presented in this paper, together with the reported partial uncoupling and larger fraction of apoptotic cells in the transformed cell line [10] , and the reversion of each of these phenotypes by expression of the GEF-DN (ref. [10] , Fig. 8 ), indicate that activation of the Ras pathway strikingly impacts on energy and signaling-related aspects of mitochondria functionality that in turn may affect the terminal phenotype of transformed cells.
